Evidence map›Paper›PMID 35884548›Full record

ReviewCancers2022

Clinical Applications of Immuno-PET in Lymphoma: A Systematic Review.

Elizabeth Katherine Anna Triumbari, David Morland, Riccardo Laudicella, Matteo Bauckneht, Domenico Albano, Salvatore Annunziata

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Ultra-low dose immunoPET usingFrontiers in medicine · 2025
    Article
  3. Review
  4. A novel [Frontiers in immunology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Elizabeth Katherine Anna TriumbariUnità di Medicina Nucleare, TracerGLab, Dipartimento di Radiologia, Radioterapia ed Ematologia, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Rome, Italy.ORCID 0000-0001-6932-2276
David MorlandUnità di Medicina Nucleare, TracerGLab, Dipartimento di Radiologia, Radioterapia ed Ematologia, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Rome, Italy.ORCID 0000-0001-8738-4841
Riccardo LaudicellaDepartment of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, via Consolare Valeria n1, 98125 Messina, Italy.
Matteo BaucknehtDepartment of Health Sciences (DISSAL), University of Genova, 16132 Genova, Italy.ORCID 0000-0002-1937-9116
Domenico AlbanoNuclear Medicine, ASST SpedaliCivili Brescia, 25122 Brescia, Italy.ORCID 0000-0003-0810-6494
Salvatore AnnunziataUnità di Medicina Nucleare, TracerGLab, Dipartimento di Radiologia, Radioterapia ed Ematologia, Fondazione Policlinico Universitario A. Gemelli, IRCCS, 00168 Rome, Italy.
Agostino Gemelli University Polyclinic · ITAzienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia · ITOspedale Policlinico San Martino · ITUniversity of Messina · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

68Ga-pentixafor89Zrhumanimmuno-PETlymphomasystematic review

Identifiers

PMID35884548
PMCPMC9316480
OpenAlexW4285802582

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.